+91-9660032889
support@mysiponline.com
WhiteOak Capital Pharma and Healthcare Fund - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Very High
-
₹13.36
(-0.88%)
Current NAV 20-12-2024
-
0%
Returns
-
Min. SIP ₹100
Min. Investment ₹500
Fund Suitability Test
Asset Allocation (As on 31-Oct-2024)
Allocation of Equity and Debt Asset Classes.
- Equity 85.22%
- Debt 3.47%
Market Cap Allocation Of Equity
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Small Cap | 33.6 |
| Large Cap | 27.08 |
| Mid Cap | 24.54 |
Sector Allocation of Equity
Weightage of Portfolio Among Different Sectors.
Pharmaceuticals & Biotechnology
Healthcare Services
Healthcare Equipment & Supplies
Industrial Products
Financial Technology (Fintech)
Current Stocks Holdings of Equity
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 20-Dec-2024 |
Holdings | PE Ratio 20-Dec-2024 |
1Y Return |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Large Cap | Pharmaceuticals & Biotechnology (48.78) | 9.58% | 39.26 | 46.84% |
| Cipla Limited | Large Cap | Pharmaceuticals & Biotechnology (48.78) | 5.53% | 26.56 | 19.21% |
| Max Healthcare Institute Limited | Mid Cap | Healthcare Services (99.42) | 5.11% | 107.13 | 79.45% |
| Poly Medicure Limited | Small Cap | Healthcare Equipment & Supplies (81.69) | 3.59% | 89.27 | 76.02% |
| Aurobindo Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (48.78) | 3.49% | 20.12 | 20.13% |
| Mankind Pharma Limited | Large Cap | Pharmaceuticals & Biotechnology (48.78) | 3.28% | 53.42 | 49.78% |
| Lupin Limited | Mid Cap | Pharmaceuticals & Biotechnology (132.95) | 3.22% | 167.31 | 197.56% |
| Divis Laboratories Limited | Large Cap | Pharmaceuticals & Biotechnology (48.78) | 2.67% | 84.35 | 61.24% |
| Krishna Institute Of Medical Sciences Limited | Small Cap | Healthcare Services | 2.63% | - | 0% |
| Piramal Pharma Limited | Small Cap | Pharmaceuticals & Biotechnology (22.59) | 2.6% | 0 | -26.02% |
| IPCA Laboratories Limited | Mid Cap | Pharmaceuticals & Biotechnology (48.78) | 2.56% | 61.4 | 50.79% |
| Glenmark Pharmaceuticals Limited | Mid Cap | Pharmaceuticals & Biotechnology (48.78) | 2.55% | -49.93 | 95.91% |
| Dr. Reddys Laboratories Limited | Large Cap | Pharmaceuticals & Biotechnology | 2.43% | - | 0% |
| Strides Pharma Science Limited | Small Cap | Pharmaceuticals & Biotechnology (48.78) | 2.15% | 27.17 | 18.23% |
| Ajanta Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (48.78) | 2.08% | 40.56 | 49.87% |
| Apollo Hospitals Enterprise Limited | Large Cap | Healthcare Services (99.42) | 2.07% | 87.74 | 33.86% |
| Neuland Laboratories Limited | Small Cap | Pharmaceuticals & Biotechnology (48.78) | 2.05% | 64.09 | 179.49% |
| Vijaya Diagnostic Centre Limited | Small Cap | Healthcare Services (99.42) | 1.95% | 80.11 | 53.4% |
| Fortis Healthcare Limited | Mid Cap | Healthcare Services (99.42) | 1.84% | 77.69 | 72.52% |
| Torrent Pharmaceuticals Limited | Large Cap | Pharmaceuticals & Biotechnology (48.78) | 1.52% | 64.68 | 60.57% |
| Ami Organics Limited | Small Cap | Pharmaceuticals & Biotechnology (48.78) | 1.38% | 93.45 | 97.83% |
| Global Health Limited | Mid Cap | Healthcare Services (99.42) | 1.35% | 60.48 | 19.47% |
| Aster DM Healthcare Limited | Small Cap | Healthcare Services (99.42) | 1.32% | 4.51 | 26.01% |
| Rainbow Childrens Medicare Limited | Small Cap | Healthcare Services (99.42) | 1.32% | 68.64 | 41.9% |
| Jupiter Life Line Hospitals Limited | Small Cap | Healthcare Services | 1.27% | - | 0% |
| Supriya Lifescience Limited | Small Cap | Pharmaceuticals & Biotechnology (29.86) | 1.25% | 0 | 0% |
| Shaily Engineering Plastics Limited | Small Cap | Industrial Products (47.17) | 1.06% | 90.83 | 326.23% |
| Thyrocare Technologies Limited | Small Cap | Healthcare Services (99.42) | 1.05% | 59.75 | 54.13% |
| Gufic Biosciences Limited | Small Cap | Pharmaceuticals & Biotechnology (55.16) | 1.01% | 36 | 45.63% |
| PB Fintech Limited | Mid Cap | Financial Technology (Fintech) (76.58) | 1% | 615.37 | 84.19% |
| Alkem Laboratories Limited | Mid Cap | Pharmaceuticals & Biotechnology (38.82) | 0.98% | 57.92 | -8.63% |
| Eris Lifesciences Limited | Small Cap | Pharmaceuticals & Biotechnology (48.78) | 0.94% | 53.71 | 57.35% |
| Shilpa Medicare Limited | Small Cap | Pharmaceuticals & Biotechnology (48.78) | 0.94% | 130.3 | 129.21% |
| RPG Life Sciences Limited | Small Cap | Pharmaceuticals & Biotechnology (55.16) | 0.92% | 29.33 | 90% |
| AstraZeneca Pharma India Limited | Small Cap | Pharmaceuticals & Biotechnology (55.16) | 0.91% | 96.24 | 61.67% |
| Healthcare Global Enterprises Limited | Small Cap | Healthcare Services (99.42) | 0.9% | 129.87 | 46% |
| Kovai Medical Center and Hospital Limited | Small Cap | Healthcare Services (99.42) | 0.88% | 0 | 85.41% |
| Blue Jet Healthcare Ltd | Small Cap | Pharmaceuticals & Biotechnology (48.78) | 0.8% | 0 | 59.82% |
| Alembic Pharmaceuticals Limited | Small Cap | Pharmaceuticals & Biotechnology (48.78) | 0.8% | 31.82 | 37.78% |
| Laurus Labs Limited | Small Cap | Pharmaceuticals & Biotechnology (46.65) | 0.79% | 0 | 9.05% |
| Jubilant Pharmova Limited | Small Cap | Pharmaceuticals & Biotechnology (55.16) | 0.6% | -300.03 | 96.3% |
| Suven Pharmaceuticals Limited | Small Cap | Pharmaceuticals & Biotechnology (48.78) | 0.49% | 123.65 | 75.76% |
| Gland Pharma Limited | Mid Cap | Pharmaceuticals & Biotechnology (48.78) | 0.36% | 42.04 | -2.56% |
Discover More with Premium Access
View Stock InformationMarket Cap Allocation Of Debt
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Others | 3.47 |
Sector Allocation of Debt
Weightage of Portfolio Among Different Sectors.
Current Stocks Holdings of Debt
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 01-Jan-1970 |
Holdings | PE Ratio 01-Jan-1970 |
1Y Return |
|---|---|---|---|---|---|
| 91 Days Tbill (MD 03/01/2025) | 1.28% | - | 0% | ||
| 91 Days Tbill (MD 21/11/2024) | 0.86% | - | 0% | ||
| 182 Days Tbill (MD 12/12/2024) | 0.73% | - | 0% | ||
| 91 Days Tbill (MD 12/12/2024) | 0.26% | - | 0% | ||
| 364 Days Tbill (MD 12/12/2024) | 0.17% | - | 0% | ||
| 182 Days Tbill (MD 05/12/2024) | 0.13% | - | 0% | ||
| 364 Days Tbill (MD 09/01/2025) | 0.04% | - | 0% |
Discover More with Premium Access
View Stock Information
Take test again
Chat with usFrequently Asked Questions
What is Market cap allocation in the portfolio?
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.
Top 5 holdings for WhiteOak Capital Pharma and Healthcare Fund?
The top holdings of this fund are
How do I create a good mutual fund portfolio?
Building a good portfolio requires proper research and knowing about goals that need to be achieved. Set a boundary for your risk capacity, study about different funds and look at its past performance. Balance portfolio according to set goals and stay informed.
How to maintain a good portfolio?
Timely monitoring of the portfolio keeps us aware of the changes in the ongoing market trends. It helps in making plans for any policy change.
What is sector allocation in the portfolio?
The distribution of assets among various economic sectors is referred to as sector allocation in a portfolio. These sectors include technology, healthcare, financial, energy, and many others.
Top 5 Sector for WhiteOak Capital Pharma and Healthcare Fund?
The major sectors of this fund are .
What is the ideal number of funds to have in a portfolio?
There is no ideal number, but it is always advisable to keep 4-5 funds in the portfolio as it can be easy to manage them and correct decisions can be taken according to it. Diversification is the key to manage and balance your portfolio for smooth growth.
How does risk tolerance play a role in determining portfolio allocation?
Risk tolerance is an important factor in maintaining portfolio allocation. With the correct mix of assets, the value of investments can improve significantly.